IP Verse

Crispr-Based Genome Modification And Regulation

Patent No. EP2928496 (titled "Crispr-Based Genome Modification And Regulation") was filed by Sigma Aldrich on Dec 5, 2013. The application was issued on Oct 9, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREJul 9, 2020MATHYS & SQUIRE
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBJul 9, 2020LAHRTZ
SCHLICHJul 9, 2020SCHLICH
BASFJul 8, 2020EISENFUHR SPEISER
COOLEY UKJul 8, 2020COOLEY UK
GRUNDFeb 4, 2020GRUND
BAYER BAYERDec 23, 2019COHAUSZ & FLORACK
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBNov 22, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2928496

SIGMA ALDRICH
Application Number
EP13859964A
Filing Date
Dec 5, 2013
Status
Revoked
Nov 4, 2022
Publication Date
Oct 9, 2019
External Links
Slate, Register , Google Patents